
Realize the drops that cure presbyopia
The cycle of studies on the active substance UN844 should be completed by 2023. Edited by Novartis, the drops in the design phase will deeply affect the crystalline glass of the eye. No declaration regarding the release of the active substance on the market.
Giovanni Sapere
















